AU2001232079A1 - Water dispersible formulation of paroxetine - Google Patents
Water dispersible formulation of paroxetineInfo
- Publication number
- AU2001232079A1 AU2001232079A1 AU2001232079A AU2001232079A AU2001232079A1 AU 2001232079 A1 AU2001232079 A1 AU 2001232079A1 AU 2001232079 A AU2001232079 A AU 2001232079A AU 2001232079 A AU2001232079 A AU 2001232079A AU 2001232079 A1 AU2001232079 A1 AU 2001232079A1
- Authority
- AU
- Australia
- Prior art keywords
- paroxetine
- water dispersible
- dispersible formulation
- formulation
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960002296 paroxetine Drugs 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0003232.6 | 2000-02-11 | ||
GBGB0003232.6A GB0003232D0 (en) | 2000-02-11 | 2000-02-11 | Novel composition |
PCT/GB2001/000569 WO2001058449A1 (en) | 2000-02-11 | 2001-02-09 | Water dispersible formulation of paroxetine |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001232079A1 true AU2001232079A1 (en) | 2001-11-01 |
AU2001232079B2 AU2001232079B2 (en) | 2004-11-25 |
Family
ID=9885464
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU3207901A Pending AU3207901A (en) | 2000-02-11 | 2001-02-09 | Water dispersible formulation of paroxetine |
AU2001232079A Ceased AU2001232079B2 (en) | 2000-02-11 | 2001-02-09 | Water dispersible formulation of paroxetine |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU3207901A Pending AU3207901A (en) | 2000-02-11 | 2001-02-09 | Water dispersible formulation of paroxetine |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030186938A1 (en) |
EP (1) | EP1255549A1 (en) |
AU (2) | AU3207901A (en) |
CA (1) | CA2399411A1 (en) |
GB (1) | GB0003232D0 (en) |
HK (1) | HK1051486A1 (en) |
NO (1) | NO20023785L (en) |
WO (1) | WO2001058449A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK200100341A (en) * | 2001-03-02 | 2002-09-03 | Gea Farmaceutisk Fabrik As | Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
ES2261726T3 (en) * | 2001-08-09 | 2006-11-16 | Smithkline Beecham Plc | COMPOSITION THAT INCLUDES PAROXETINE AND A PHARMACEUTICALLY ACCEPTABLE GLICIRRICINATE SALT. |
US20060039975A1 (en) * | 2004-08-20 | 2006-02-23 | Zalman Vilkov | Paroxetine formulations |
JP2009537478A (en) * | 2006-05-13 | 2009-10-29 | ノヴォ ノルディスク アクティーゼルスカブ | Tablet formulation containing repaglinide and metformin |
US20100016322A1 (en) * | 2007-02-28 | 2010-01-21 | Nagesh Nagaraju | Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same |
CN102631329A (en) * | 2012-04-12 | 2012-08-15 | 无锡万全医药技术有限公司 | Oral paroxetine disintegrating tablet and preparation process thereof |
CN104382870A (en) * | 2014-10-30 | 2015-03-04 | 万全万特制药江苏有限公司 | Compound containing polacrilin potassium-paroxetine |
CN106309363A (en) * | 2016-09-24 | 2017-01-11 | 万特制药(海南)有限公司 | Paroxetine hydrochloride oral suspension and preparation method thereof |
CN112137970A (en) * | 2019-06-28 | 2020-12-29 | 北京万全德众医药生物技术有限公司 | Paroxetine hydrochloride orally disintegrating tablet and preparation process thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
GB9305175D0 (en) * | 1993-03-13 | 1993-04-28 | Smithkline Beecham Plc | Novel process |
GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
US5856493A (en) * | 1995-02-06 | 1999-01-05 | Smithkline Beecham Corporation | Process for making novel form of paroxeting hydrochloride anhydrate |
US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
IT1276160B1 (en) * | 1995-11-22 | 1997-10-27 | Recordati Chem Pharm | READY-RELEASE ORAL PHARMACEUTICAL COMPOSITIONS FOR EXTEMPORARY SUSPENSIONS |
GB9605828D0 (en) * | 1996-03-20 | 1996-05-22 | Smithkline Beecham Plc | Treatment method |
GB9623359D0 (en) * | 1996-11-09 | 1997-01-08 | Smithkline Beecham Plc | Novel process |
GB9700690D0 (en) * | 1997-01-15 | 1997-03-05 | Smithkline Beecham Plc | Novel process |
EA199901098A1 (en) * | 1997-05-29 | 2000-08-28 | Смитклайн Бичам Корпорейшн | NEW METHOD |
US5955475A (en) * | 1997-06-30 | 1999-09-21 | Endo Pharmaceuticals Inc. | Process for manufacturing paroxetine solid dispersions |
GB9714841D0 (en) * | 1997-07-14 | 1997-09-17 | Smithkline Beecham Plc | Treatment method |
BR9813808A (en) * | 1997-12-19 | 2002-05-28 | Smithkline Beecham Corp | Process for producing tablets for dispersion in the bite |
IL137346A0 (en) * | 1998-01-21 | 2001-07-24 | Glaxo Group Ltd | Pharmaceutically active morpholinol |
US6699882B2 (en) * | 1998-03-24 | 2004-03-02 | Smithkline Beecham P.L.C. | Paroxetine compositions |
GB9808896D0 (en) * | 1998-04-25 | 1998-06-24 | Smithkline Beecham Plc | Novel compound |
US6168805B1 (en) * | 1998-05-07 | 2001-01-02 | Endo Pharmaceuticals, Inc. | Aqueous process for manufacturing paroxetine solid dispersions |
GB9810181D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulations |
US6300343B1 (en) * | 1998-06-16 | 2001-10-09 | Smithkline Beecham Corporation | Method of treatment |
CH689805A8 (en) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it. |
US6734213B2 (en) * | 1999-01-20 | 2004-05-11 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
WO2000078290A2 (en) * | 1999-06-22 | 2000-12-28 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a salt of paroxetine |
ES2159260B1 (en) * | 1999-06-22 | 2002-05-01 | Smithkline Beechan Plc | NEW PAROXETINE METHANOSULPHONATE COMPOSITION |
GB9923748D0 (en) * | 1999-10-07 | 1999-12-08 | Glaxo Group Ltd | Chemical compounds |
-
2000
- 2000-02-11 GB GBGB0003232.6A patent/GB0003232D0/en not_active Ceased
-
2001
- 2001-02-09 WO PCT/GB2001/000569 patent/WO2001058449A1/en not_active Application Discontinuation
- 2001-02-09 US US10/203,321 patent/US20030186938A1/en not_active Abandoned
- 2001-02-09 EP EP01904162A patent/EP1255549A1/en not_active Withdrawn
- 2001-02-09 AU AU3207901A patent/AU3207901A/en active Pending
- 2001-02-09 AU AU2001232079A patent/AU2001232079B2/en not_active Ceased
- 2001-02-09 CA CA002399411A patent/CA2399411A1/en not_active Abandoned
-
2002
- 2002-08-09 NO NO20023785A patent/NO20023785L/en not_active Application Discontinuation
-
2003
- 2003-03-28 HK HK03102264.2A patent/HK1051486A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002225855A1 (en) | Preparation of nanocrystallites | |
AU2001268659A1 (en) | Water treatment compositions | |
AU2001242808A1 (en) | Water closet | |
AU2001231045A1 (en) | Personal cleansing compositions | |
AU2637801A (en) | Methods of forming semiconductor structures | |
AU2001294912A1 (en) | Hydroxyesters of 7-desmethylrapamycin | |
AU2001269331A1 (en) | Cleaning and doping of tubulars | |
AU2001259702A1 (en) | Tissue regrafting | |
AU2001281140A1 (en) | Anti-plasmodium compositions and methods of use | |
AU2001263697A1 (en) | Water fitting | |
AU2001249855A1 (en) | Aqueous mineral compositions and methods for their use | |
AU2001241837A1 (en) | Processed tissue webs | |
AU2001270626A1 (en) | Floating type formulation of agricultural agents | |
AU2001232079A1 (en) | Water dispersible formulation of paroxetine | |
AU2001285914A1 (en) | Improved swellable phyllosilicates | |
AU3207901A (en) | Water dispersible formulation of paroxetine | |
AU2001276347A1 (en) | Water swellable compositions | |
AU2001284763A1 (en) | Preparation of risperidone | |
AU2001241771A1 (en) | Use of avocado-soybean unsaponifiable preparations | |
AU2001244108A1 (en) | Formulations for states of dehydration | |
AU2001294062A1 (en) | Method of treating aqueous compositions | |
AU2879801A (en) | Effervescent compositions comprising nimesulide | |
AU2001245950A1 (en) | Preparation of deoxynucleosides | |
AU2001255773A1 (en) | Human caspase-14 compositions | |
AU2001281950A1 (en) | Regulation of human thimet oligopeptidase-like enzyme |